Articles in section Mergers & Acquisitions
| << Licensing | 591 articles | Opinion & Analysis >> |
| Pages 1 2 3 4 5 .. 60 | Next >> |
-
Eli Lilly Acquires Gene Therapy Company Prevail Therapeutics for US$1.04 B
-
Roche Advances Infectious Disease Diagnostic Portfolio with US$1.8 B GenMark Acquisition
-
Jazz Pharmaceuticals Bets on Cannabis-based Medicines with US$7.2 B GW Pharmaceuticals Buy
-
Amgen Spends US$1.9 B on Five Prime to Boost Cancer Pipeline
-
Takeda Continues Divestment Spree with US$1.3 B Teijin Pharma Deal to Reduce Debt
-
Merck & Co. Hands Over US$1.85 B to Acquire Pandion Therapeutics
-
Boehringer Ingelheim Buys ADC Specialist NBE-Therapeutics for US$1.43 B
-
Horizon Continues to Build Rare Disease Pipeline with US$3.05 B Viela Buy
-
Sanofi Bolsters Immunology Portfolio with US$1.45 B Kymab Acquisition
-
Bayer Highlights Cell and Gene Therapy Commitment with US$4 B Asklepios Buyout
RSS